BioSpace News Archive

Genetown

ALKU Releases Life Sciences eBook Targeting New MDR Classifications

ALKU’s Life Sciences division is excited to announce the release of its first eBook: 5 Important Factors of the New MDR Classification Requirements for Medical Devices. In an effort to better support its customers’ needs and provide industry insight, ALKU wanted to offer additional support through eBooks.

February 22, 2019

·

2 min read

Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C

Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment, has closed four new investments across four countries over the past few months

February 22, 2019

·

6 min read

Business

Visioneering Launches NaturalVue® Brand Contact Lenses for Myopia Progression Control & Presbyopia in the United Kingdom

US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses Visioneering Technologies, Inc (ASX: VTI) (‘Visioneering’ or ‘The Company’) has announced its launch into the UK.

February 22, 2019

·

1 min read

Business

Make 2019 Your Year of Health with Nupure Probiflor and Probipure Junior Probiotics -- Coming Soon to Amazon

AixSwiss B.V.'s Nupure probiotics is perfect to help you make 2019 your year of health.

February 22, 2019

·

1 min read

Deals

Co-Diagnostics, Inc. Regains Compliance with NASDAQ Listing Standards

Co-Diagnostics, Inc. announced that it has received written notice from the Nasdaq Stock Market Listing Qualifications Staff on February 19, 2019, indicating that the Company has regained compliance with the minimum stockholders’ equity requirement as set forth in Nasdaq Capital Markets Listing Rule 5550.

February 22, 2019

·

2 min read

Deals

Completion of a Successful Management Buyout Transaction At NuChem Therapeutics

NuChem Therapeutics Inc., a drug discovery and development contract research organization located in Montreal and specializing in medicinal and synthetic chemistry services, has completed a successful Management Buyout transaction.

February 22, 2019

·

3 min read

Business

Starboard to Nominate a Full Slate of Highly Qualified Director Candidates for Election at Magellan Health’s 2019 Annual Meeting

Starboard Value LP announced that it will be nominating a full slate of highly qualified candidates for election to the Board of Directors at the Company’s 2019 Annual Meeting of Shareholders.

February 22, 2019

·

5 min read

Drug Development

Phase 3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with Localized Prostate Cancer

Data Presented at the 2019 Genitourinary Cancers Symposium Reinforces Benefits of Short Course of Treatment Using Stereotactic Body Radiation Therapy for Low- or Intermediate-Risk Prostate Cancer

February 22, 2019

·

5 min read

Business

FirstLight Home Care Expands Leadership Team to Support Rapid Growth

National non-medical home care provider announces several new hires as company advances

February 22, 2019

·

3 min read

Deals

Bausch Health Commences Cash Tender Offers And Consent Solicitation For Up To $1,250,000,000 Aggregate Purchase Price

Bausch Health Companies Inc. announced that it has commenced cash tender oﬀers to purchase up to $1,250,000,000 aggregate purchase price of its outstanding notes listed in the table below.

February 22, 2019

·

15 min read